Stay updated on Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new page revision (v3.5.4) was added and the previous revision (v3.5.3) removed, signaling a minor update to the page’s versioning metadata. This update does not change the study details or any visible content.
    Difference
    0.1%
    Check dated 2026-05-15T14:27:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    An update to the page’s displayed release/version identifier (from v3.5.2 to v3.5.3), indicating a site revision rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:31.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Updated the site revision label from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:17:37.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:19:19.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior government funding notice (Revision: v3.4.1) was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:56:34.000Z thumbnail image

Stay in the know with updates to Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.